Jieyao Li

机构：First Affiliated Hospital of Zhengzhou University

发表论文 34 篇 · 总被引 1008 次 · h-index 16

代表论文

• CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer (2017 · OncoImmunology · 被引 296)
• PD-1 signaling limits expression of phospholipid phosphatase 1 and promotes intratumoral CD8+ T cell ferroptosis (2024 · Immunity · 被引 124)
• Expression and prognostic relevance of MAGE-A3 and MAGE-C2 in non-small cell lung cancer (2017 · Oncology Letters · 被引 60)
• Taurine enhances the antitumor efficacy of PD-1 antibody by boosting CD8+ T cell function (2022 · Cancer Immunology Immunotherapy · 被引 58)
• Target of obstructive sleep apnea syndrome merge lung cancer: based on big data platform (2017 · Oncotarget · 被引 56)
• XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial (2024 · Signal Transduction and Targeted Therapy · 被引 35)